The novel therapy of this peptide represents a significant development in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide907248.daneblogger.com/40709677/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment